| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | +2.4% |
| Cost of Revenue | $9.4M | +4.2% |
| Gross Profit | $566K | -20.2% |
| R&D Expense | $2.5M | -6.9% |
| SG&A Expense | $6.0M | -3.1% |
| Operating Income | -$9.3M | +3.5% |
| Interest Expense | $1.2M | -18.2% |
| Pre-tax Income | -$10.5M | +3.7% |
| Income Tax | $35K | -62.8% |
| Net Income | -$10.5M | +4.2% |
| EPS (Basic) | -$2.23 | +40.5% |
| EPS (Diluted) | -$2.23 | +40.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $599K | -17.5% |
| Accounts Receivable | $1.6M | -28.7% |
| Current Assets | $2.4M | -28.8% |
| Total Assets | $2.5M | -28.5% |
| Current Liabilities | $8.1M | +12.7% |
| Long-term Debt | $5.7M | -55.8% |
| Total Liabilities | $13.8M | -31.2% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.9M | +15.1% |
| Capital Expenditures | $34K | -45.2% |
| Investing Cash Flow | -$34K | +45.2% |
| Financing Cash Flow | $6.9M | -7.9% |
| Free Cash Flow | -$7.0M | +15.4% |
| -$22.7M |
| -37.2% |